Package 57237-106-05

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 57237-106-05
Digits Only 5723710605
Product NDC 57237-106
Product ID 57237-106_0e7b49f5-b6a5-4b9c-96d6-a28064b641dd
Description

500 TABLET, DELAYED RELEASE in 1 BOTTLE (57237-106-05)

Marketing

Marketing Status
Marketed Since 2014-10-24
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Divalproex Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0e7b49f5-b6a5-4b9c-96d6-a28064b641dd", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["6316061c-9758-4f38-9cb2-7ca833dd20bf"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (57237-106-01)", "package_ndc": "57237-106-01", "marketing_start_date": "20141024"}, {"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE (57237-106-05)", "package_ndc": "57237-106-05", "marketing_start_date": "20141024"}], "brand_name": "Divalproex Sodium", "product_id": "57237-106_0e7b49f5-b6a5-4b9c-96d6-a28064b641dd", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "57237-106", "generic_name": "Divalproex Sodium", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "125 mg/1"}], "application_number": "ANDA090554", "marketing_category": "ANDA", "marketing_start_date": "20141024", "listing_expiration_date": "20261231"}